170 related articles for article (PubMed ID: 21709098)
21. Biological measure of compliance to Artesunate plus Amodiaquine association: interest in a Mono-Desethyl-Amodiaquine blood assay?
Sarrassat S; Sakho M; Le Hesran JY
Acta Trop; 2009 Apr; 110(1):1-6. PubMed ID: 19056331
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.
Orrell C; Little F; Smith P; Folb P; Taylor W; Olliaro P; Barnes KI
Eur J Clin Pharmacol; 2008 Jul; 64(7):683-90. PubMed ID: 18415093
[TBL] [Abstract][Full Text] [Related]
23. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Fortin A; Verbeeck RK; Jansen FH
Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
[TBL] [Abstract][Full Text] [Related]
24. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
Quang NN; Chavchich M; Anh CX; Birrell GW; van Breda K; Travers T; Rowcliffe K; Edstein MD
Am J Trop Med Hyg; 2018 Jul; 99(1):65-72. PubMed ID: 29741150
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.
Höglund R; Moussavi Y; Ruengweerayut R; Cheomung A; Äbelö A; Na-Bangchang K
Malar J; 2016 Feb; 15():129. PubMed ID: 26928448
[TBL] [Abstract][Full Text] [Related]
27. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP
P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089
[TBL] [Abstract][Full Text] [Related]
28. Amodiaquine during pregnancy.
Bhattarai A; Maini-Thapar M; Ali AS; Björkman A
Lancet Infect Dis; 2004 Dec; 4(12):721-2; discussion 722. PubMed ID: 15567117
[No Abstract] [Full Text] [Related]
29. Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.
Ogutu B; Juma E; Obonyo C; Jullien V; Carn G; Vaillant M; Taylor WR; Kiechel JR
Malar J; 2014 Dec; 13():498. PubMed ID: 25515698
[TBL] [Abstract][Full Text] [Related]
30. Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
Siqueira AM; Alencar AC; Melo GC; Magalhaes BL; Machado K; Alencar Filho AC; Kuehn A; Marques MM; Manso MC; Felger I; Vieira JL; Lameyre V; Daniel-Ribeiro CT; Lacerda MV
Clin Infect Dis; 2017 Jan; 64(2):166-174. PubMed ID: 27988484
[TBL] [Abstract][Full Text] [Related]
31. [Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin].
Osorio L; Pérez Ldel P; González IJ
Biomedica; 2007 Mar; 27(1):133-40. PubMed ID: 17546230
[TBL] [Abstract][Full Text] [Related]
32. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
Hossain MS; Commons RJ; Douglas NM; Thriemer K; Alemayehu BH; Amaratunga C; Anvikar AR; Ashley EA; Asih PBS; Carrara VI; Lon C; D'Alessandro U; Davis TME; Dondorp AM; Edstein MD; Fairhurst RM; Ferreira MU; Hwang J; Janssens B; Karunajeewa H; Kiechel JR; Ladeia-Andrade S; Laman M; Mayxay M; McGready R; Moore BR; Mueller I; Newton PN; Thuy-Nhien NT; Noedl H; Nosten F; Phyo AP; Poespoprodjo JR; Saunders DL; Smithuis F; Spring MD; Stepniewska K; Suon S; Suputtamongkol Y; Syafruddin D; Tran HT; Valecha N; Van Herp M; Van Vugt M; White NJ; Guerin PJ; Simpson JA; Price RN
PLoS Med; 2020 Nov; 17(11):e1003393. PubMed ID: 33211712
[TBL] [Abstract][Full Text] [Related]
33. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar.
Andrianaranjaka V; Lin JT; Golden C; Juliano JJ; Randrianarivelojosia M
Malar J; 2013 May; 12():177. PubMed ID: 23721298
[TBL] [Abstract][Full Text] [Related]
34. The disposition of amodiaquine in Zambians and Nigerians with malaria.
Winstanley PA; Simooya O; Kofi-Ekue JM; Walker O; Salako LA; Edwards G; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1990 Jun; 29(6):695-701. PubMed ID: 2378788
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.
Onyamboko MA; Meshnick SR; Fleckenstein L; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright LL; Tshefu AK; Capparelli EV
Malar J; 2011 Feb; 10():49. PubMed ID: 21352601
[TBL] [Abstract][Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies.
Chan XHS; Chotsiri P; Capel RA; Pike J; Hanboonkunupakarn B; Lee SJ; Hanafiah M; Win YN; Cremer MA; Kiechel JR; Ogutu B; Taylor WRJ; Burton RB; Tarning J; White NJ
Br J Clin Pharmacol; 2023 Mar; 89(3):1176-1186. PubMed ID: 36256474
[TBL] [Abstract][Full Text] [Related]
38. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Mwesigwa J; Parikh S; McGee B; German P; Drysdale T; Kalyango JN; Clark TD; Dorsey G; Lindegardh N; Annerberg A; Rosenthal PJ; Kamya MR; Aweeka F
Antimicrob Agents Chemother; 2010 Jan; 54(1):52-9. PubMed ID: 19841149
[TBL] [Abstract][Full Text] [Related]
40. Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
de Kock M; Tarning J; Workman L; Allen EN; Tekete MM; Djimde AA; Bell DJ; Ward SA; Barnes KI; Denti P
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
